Further clinical studies demonstrated the efficacy of aminoglycosides G418 and gentamicin in restoring a significant amount of functional CFTR and dystrophin proteins in CF and Duchenne muscular dystrophy (DMD), respectively (Table 2). The gene discussed is CFTR; the disease is Duchenne muscular dystrophy.